Although the record-breaking deal activity of 2021 spilled over into 2022, headwinds in the first quarter developed into a significant slowdown during the rest of 2022, with an expectation of continued slowness as we enter...more
1/30/2023
/ Acquisitions ,
Buyers ,
Capital Markets ,
CFIUS ,
Coronavirus/COVID-19 ,
Cryptocurrency ,
Department of Justice (DOJ) ,
Domestic Dealmaking ,
Environmental Social & Governance (ESG) ,
EU ,
Federal Trade Commission (FTC) ,
Financial Institutions ,
Financial Services Industry ,
Global Dealmaking ,
Investment ,
Investors ,
Mergers ,
Pharmaceutical Industry ,
Private Equity ,
Publicly-Traded Companies ,
Real Estate Market ,
Securities and Exchange Commission (SEC) ,
Sellers ,
Special Purpose Acquisition Companies (SPACs) ,
Technology
Williams: Court of Chancery Finds Poison Pill Unenforceable -
In February, the Delaware Court of Chancery held that a shareholder rights plan (a "poison pill") adopted by The Williams Companies, Inc. at the onset of the...more
7/30/2021
/ Acquisition Agreements ,
Acquisitions ,
Activist Investors ,
Board of Directors ,
Breach of Contract ,
Buyers ,
Coronavirus/COVID-19 ,
Corporate Counsel ,
Domestic Dealmaking ,
Earn-Outs ,
Global Dealmaking ,
Material Adverse Effects ,
Mergers ,
Motion to Dismiss ,
Poison Pill ,
Private Equity Firms ,
Purchase Agreement ,
Sellers ,
Shareholders